263 results
Thumbnail

D1.82 - Diagnostic challenges in amoxicillin-clavulanate anaphylaxis: an inconclusive in vitro study – Case Report

Thumbnail

D1.83 - Asthma and multi-food allergy were risk factors for Oral Food Challenge failure

Thumbnail

D1.84 - IgE-mediated allergy to chlorhexidine: case report

Thumbnail

D1.85 - Basophil activation test in β-Lactam Anaphylaxis: A Case Series from a Tertiary Hospital

Thumbnail

D1.86 - Hypersensitivity Reaction to Lugol’s Solution: A Case Report

Thumbnail

D2.08 - Post-Traumatic Stress Disorder Associated with Anaphylaxis

Thumbnail

D2.194 - Persisten severe cow's milk allergy with successful oral immunotherapy in adulthood

Thumbnail

- D3.15 - Mislabeling of Anaphylaxis in the Emergency Department: A Retrospective Study at King Abdulaziz University Hospital, Jeddah

Thumbnail

D3.82 - Could Lipid Transfer Protein Induced Anaphylaxis Be a Surprising Outcome of Sleeve Gastrectomy?

Thumbnail

D3.195 - Reasons for declining venom immunotherapy and its burden on patients' daily lives

Thumbnail

D3.198 - Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy

Thumbnail

D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report

Thumbnail

D3.268 - Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production

Thumbnail

D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings

Thumbnail

D3.270 - A novel workflow for cell metabolomics: impact of anaphylaxis in a human endothelial system

Thumbnail

D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients

Thumbnail

D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria

Thumbnail

D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Thumbnail

D3.275 - Anaphylaxis caused by polyhexanide

Thumbnail

D3.276 - Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity